Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.74 Insider Own0.40% Shs Outstand193.13M Perf Week19.51%
Market Cap2.99B Forward P/E- EPS next Y-0.58 Insider Trans-61.04% Shs Float193.13M Perf Month41.81%
Income-126.20M PEG- EPS next Q-0.23 Inst Own- Short Float7.86% Perf Quarter39.89%
Sales141.30M P/S21.19 EPS this Y-10.20% Inst Trans0.00% Short Ratio4.41 Perf Half Y98.72%
Book/sh1.30 P/B11.92 EPS next Y41.40% ROA-38.50% Target Price16.22 Perf Year38.64%
Cash/sh2.40 P/C6.46 EPS next 5Y10.00% ROE-158.70% 52W Range6.73 - 16.00 Perf YTD21.09%
Dividend- P/FCF- EPS past 5Y-16.50% ROI-71.10% 52W High-3.13% Beta1.93
Dividend %- Quick Ratio5.40 Sales past 5Y12.10% Gross Margin72.90% 52W Low130.31% ATR0.85
Employees209 Current Ratio5.40 Sales Q/Q-24.40% Oper. Margin-80.40% RSI (14)70.82 Volatility6.59% 6.08%
OptionableYes Debt/Eq0.60 EPS Q/Q-10.30% Profit Margin-89.30% Rel Volume2.03 Prev Close15.56
ShortableYes LT Debt/Eq0.54 EarningsFeb 08 BMO Payout- Avg Volume3.44M Price15.50
Recom1.80 SMA2017.60% SMA5030.21% SMA20056.57% Volume7,007,474 Change-0.39%
Jan-22-18Upgrade Leerink Partners Mkt Perform → Outperform
Jan-22-18Reiterated Stifel Buy $15 → $20
Sep-11-17Reiterated Stifel Buy $13 → $15
May-03-17Upgrade JP Morgan Neutral → Overweight
Feb-03-17Reiterated Stifel Buy $8 → $13
Feb-03-17Downgrade JP Morgan Overweight → Neutral
Jan-30-17Downgrade Leerink Partners Outperform → Mkt Perform
Sep-26-16Reiterated Piper Jaffray Overweight $7 → $10
Sep-26-16Reiterated Leerink Partners Outperform $6 → $9
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Jan-23-18 08:10AM  Todays Research Reports on Stocks to Watch: Array BioPharma and Sorrento Therapeutics ACCESSWIRE
Jan-22-18 11:56AM  Why Array BioPharma Inc. Is Soaring Motley Fool +18.42%
11:05AM  DEADLINE ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE
10:38AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline: January 22, 2018 ACCESSWIRE
Jan-20-18 10:05AM  Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3 Trial PR Newswire
Jan-18-18 02:00PM  ARRY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 ACCESSWIRE
10:30AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Jan-17-18 02:44PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE
02:32PM  FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Array BioPharma Inc. (Nasdaq: ARRY) To Contact The Firm GlobeNewswire
01:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY ACCESSWIRE
Jan-16-18 11:36AM  The Klein Law Firm Reminds Shareholders of a Class Action on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 (ARRY) ACCESSWIRE -5.40%
10:37AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline: January 22, 2018 ACCESSWIRE
08:00AM  Array BioPharma to Present Updated Phase 3 BEACON CRC Safety Lead-In Results of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the 2018 Gastrointestinal Cancers Symposium PR Newswire
Jan-14-18 01:00PM  ARRY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 ACCESSWIRE
Jan-13-18 07:31AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY ACCESSWIRE
Jan-12-18 04:23PM  ARRY LOSS ALERT: Rosen Law Firm Reminds Array Biopharma Inc. Investors of Important January 22 Deadline in Class Action ARRY GlobeNewswire
08:04AM  See what the IHS Markit Score report has to say about Array Biopharma Inc. Markit
08:00AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE
Jan-11-18 05:18PM  ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm ACCESSWIRE
05:00PM  The Klein Law Firm Reminds Shareholders of a Class Action Commenced on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 (ARRY) ACCESSWIRE
Jan-10-18 06:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY ACCESSWIRE
08:10AM  Todays Research Reports on Trending Tickers: Array BioPharma and Nektar Therapeutics ACCESSWIRE
03:00AM  Stocks Showing Market Leadership: Array Biopharma Earns 91 RS Rating Investor's Business Daily
Jan-09-18 11:43AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE +7.63%
10:37AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
08:03AM  See what the IHS Markit Score report has to say about Array Biopharma Inc. Markit
Jan-08-18 12:45PM  ARRY INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 ACCESSWIRE
Jan-06-18 12:46PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY ACCESSWIRE
Jan-05-18 11:50AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE
10:36AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Jan-03-18 04:00PM  The Klein Law Firm Reminds Shareholders of a Class Action on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 (ARRY) GlobeNewswire
12:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY ACCESSWIRE
Jan-02-18 02:30PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE +5.86%
10:00AM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire
08:04AM  See what the IHS Markit Score report has to say about Array Biopharma Inc. Markit
Dec-30-17 08:15AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline ARRY Business Wire
Dec-29-17 02:09PM  ARRY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 GlobeNewswire
Dec-28-17 03:43PM  Lifshitz & Miller LLP Announces Investigation of Alteryx, Inc., Array BioPharma Inc., Bruker Corporation, Eagle Bancorp, Inc., Omega Healthcare Investors, Inc., Otsuka Holdings Co., Ltd., Tivity Health, Inc. and Triangle Capital Corporation PR Newswire
02:11PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 ARRY GlobeNewswire
12:23PM  Array BioPharma spins off cardiovascular myopathy drug research into new subsidiary American City Business Journals
Dec-27-17 07:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY ACCESSWIRE
01:14PM  The Klein Law Firm Reminds Shareholders of a Class Action on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 (ARRY) ACCESSWIRE
Dec-26-17 08:51AM  Array BioPharma (ARRY) Looks Good: Stock Adds 9.6% in Session Zacks
03:00AM  Array Biopharma Shows Rising Price Performance With Jump To 85 RS Rating Investor's Business Daily
Dec-23-17 10:15AM  Array BioPharma Inc (NASDAQ:ARRY): Does -5.8% Earnings Drop In A Year Reflect The Long-Term Trend? Simply Wall St.
08:35AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY PR Newswire
Dec-22-17 03:14PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Array Biopharma Inc. ARRY GlobeNewswire +9.55%
10:55AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
03:00AM  Array Biopharma Trying To Close In On Key Technical Benchmark Investor's Business Daily
Dec-21-17 12:37PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE
Dec-20-17 05:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY ACCESSWIRE
Dec-19-17 11:15PM  Array Biopharma Inc (ARRY) CEO Ron Squarer Sold $8.9 million of Shares GuruFocus.com
08:00AM  Array BioPharma Announces Strategic Collaboration with Pfizer PR Newswire
02:24AM  ARRY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 ACCESSWIRE
Dec-18-17 03:05PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Array BioPharma Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
02:35PM  ETFs with exposure to Array BioPharma, Inc. : December 18, 2017 Capital Cube
02:16PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 - ARRY ACCESSWIRE
Dec-16-17 08:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Array Biopharma Inc. and Certain Officers ARRY GlobeNewswire
Dec-15-17 02:29PM  Array BioPharma, Inc. Value Analysis (NASDAQ:ARRY) : December 15, 2017 Capital Cube
02:17PM  The Klein Law Firm Reminds Shareholders of a Class Action on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
10:54AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Dec-14-17 07:31AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : December 14, 2017 Capital Cube
03:00AM  Array Biopharma Scores Relative Strength Rating Upgrade; Hits Key Benchmark Investor's Business Daily
Dec-12-17 08:20AM  Todays Research Reports on Trending Tickers: Array BioPharma and Verastem, Inc. ACCESSWIRE
02:00AM  ARRY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
Dec-11-17 02:48PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Array BioPharma Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
02:00PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 Business Wire
08:55AM  Are Options Traders Betting on a Big Move in Array BioPharma (ARRY) Stock? Zacks
Dec-09-17 06:28PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Array Biopharma Inc. and Certain Officers - ARRY ACCESSWIRE
Dec-08-17 02:00PM  The Klein Law Firm Notifies Shareholders of a Class Action Commenced on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
10:53AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline: January 22, 2018 ACCESSWIRE
08:06AM  See what the IHS Markit Score report has to say about Array Biopharma Inc. Markit
Dec-07-17 05:44PM  The Klein Law Firm Notifies Shareholders of a Class Action Filed on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 (ARAY) GlobeNewswire
Dec-06-17 09:04PM  ARRY LOSS NOTICE: Rosen Law Firm Reminds Array Biopharma Inc. Investors of Important Deadline in Class Action Business Wire
08:02AM  See what the IHS Markit Score report has to say about Array Biopharma Inc. Markit
Dec-04-17 07:00PM  Array BioPharma Announces Redemption of All Remaining 3.00% Convertible Senior Notes Due 2020 PR Newswire
03:00PM  ARRY INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 Business Wire
Dec-01-17 10:52AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline: January 22, 2018 ACCESSWIRE
02:30AM  ARRY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018 GlobeNewswire
Nov-30-17 07:00PM  ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm PR Newswire
02:25PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Array BioPharma Inc. (Nasdaq: ARRY) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
08:20AM  Todays Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Array BioPharma Inc. ACCESSWIRE
08:08AM  See what the IHS Markit Score report has to say about Array Biopharma Inc. Markit
02:00AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 Business Wire
Nov-29-17 12:03PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Array BioPharma Inc. ARRY Business Wire
11:00AM  ETFs with exposure to Array BioPharma, Inc. : November 29, 2017 Capital Cube
02:00AM  The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Array BioPharma Inc. Business Wire
Nov-28-17 05:10PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Announces the Filing of a Class Action against Array Biopharma Inc. and Certain Officers ARRY GlobeNewswire
03:15PM  The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Array BioPharma Inc. Business Wire
Nov-27-17 09:17PM  Robbins Arroyo LLP: Array BioPharma Inc. (ARRY) Misled Shareholders According to a Recently Filed Class Action Business Wire
03:20PM  ARRY INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Array BioPharma Inc. Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline: January 22, 2018 PR Newswire
08:08AM  See what the IHS Markit Score report has to say about Array Biopharma Inc. Markit
Nov-22-17 04:33PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Array Biopharma, Inc. GlobeNewswire
12:43PM  ARRY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Array BioPharma Inc. Business Wire
10:00AM  Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference PR Newswire
Nov-21-17 06:25PM  ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm GlobeNewswire
04:59PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Array Biopharma, Inc. - ARRY PR Newswire
03:18PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Array Biopharma, Inc. (ARRY) PR Newswire
11:40AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 ARRY GlobeNewswire
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib, Encorafenib, Selumetinib, and Ipatasertib/GDC-0068 for the treatment of cancer, as well as ASC08/Danoprevir to treat hepatitis C virus. Its drug candidates in Phase II/registration trials comprise Larotrectinib/LOXO-101, a PanTrk inhibitor for cancer; Tucatinib/ONT-380, a HER2 inhibitor for breast cancer; and Varlitinib/ASLAN001, a Pan-HER2 inhibitor for gastric or breast cancer. In addition, the company is developing ARRY-797, a p38 inhibitor, which is in Phase II clinical trials for Lamin A/C-related dilated cardiomyopathy; Motolimod/VTX-2337, a Toll-like receptor that is under Phase II clinical studies for cancer; and Prexasertib/LY2606368, a CHK-1 inhibitor, which is in Phase II clinical studies for cancer, as well as ARRY-382, a CSF1R inhibitor that is under Phase I/II clinical trial to treat cancer. Further, it is developing GDC-0575, a CHK-1 inhibitor that is in Phase Ib clinical trial for the treatment of cancer; LOXO-292, a RET inhibitor, which is under Phase I clinical trials to treat cancer; and LOXO-195, a NTRK inhibitor that is under Phase I clinical trials to treat cancer. Array BioPharma Inc. has a collaboration agreement with Amgen, Asahi Kasei Pharma Corporation, Loxo Oncology, and Mirati Therapeutics, Inc. The company was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VAN LUNSEN GIL JDirectorJan 17Option Exercise1.9621,50042,09040,797Jan 17 05:00 PM
VAN LUNSEN GIL JDirectorJan 17Sale12.9421,500278,21019,297Jan 17 05:00 PM
Haddock JasonCFOJan 16Option Exercise3.7714,02552,87436,368Jan 16 04:28 PM
Haddock JasonCFOJan 16Sale13.737,500102,97528,868Jan 16 04:28 PM
Squarer RonCEODec 19Option Exercise5.18546,2332,829,457755,507Dec 19 09:05 PM
Squarer RonCEODec 19Sale10.93546,2335,970,327209,274Dec 19 09:05 PM
Robbins Andrew RCOODec 18Option Exercise4.96397,5001,973,225441,172Dec 19 09:05 PM
Squarer RonCEODec 18Option Exercise6.08354,5092,156,168482,712Dec 19 09:05 PM
Robbins Andrew RCOODec 18Sale10.72282,8743,032,409158,298Dec 19 09:05 PM
Squarer RonCEODec 18Sale10.73273,4382,933,990209,274Dec 19 09:05 PM
Haddock JasonCFODec 16Option Exercise0.004,387024,387Dec 19 09:07 PM
Sandor VictorChief Medical OfficerDec 16Option Exercise8.7911,28499,186197,034Dec 19 09:04 PM
Squarer RonCEODec 16Option Exercise0.0023,4370139,120Dec 19 09:05 PM
Saccomano Nicholas ACSODec 16Option Exercise0.005,468057,069Dec 19 09:05 PM
Robbins Andrew RCOODec 16Option Exercise0.0013,082049,766Dec 19 09:05 PM
VAN LUNSEN GIL JDirectorOct 27Option Exercise10.475,00052,35020,332Oct 27 04:36 PM
BAUM CHARLES MDirectorOct 27Option Exercise10.475,00052,35010,000Oct 27 04:32 PM
LEFKOFF KYLEDirectorOct 27Option Exercise10.475,00052,35017,720Oct 27 04:32 PM
Orwin John ADirectorOct 27Option Exercise10.475,00052,35010,000Oct 27 04:32 PM
Fyfe Gwen A.DirectorOct 27Option Exercise10.475,00052,35010,000Oct 27 04:28 PM
VAN LUNSEN GIL JDirectorSep 29Option Exercise10.5845,000476,10055,260Sep 29 06:23 PM
LEFKOFF KYLEDirectorSep 29Option Exercise10.5845,000476,10051,585Sep 29 06:22 PM
VAN LUNSEN GIL JDirectorSep 29Sale12.3639,928493,51015,332Sep 29 06:23 PM
LEFKOFF KYLEDirectorSep 29Sale12.3138,865478,42812,720Sep 29 06:22 PM
Haddock JasonCFOAug 14Option Exercise3.7720,00075,40020,000Aug 15 04:31 PM
Saccomano Nicholas ACSOApr 01Option Exercise0.006,875042,061Apr 04 09:42 PM
Sandor VictorChief Medical OfficerApr 01Option Exercise0.007,8120177,428Apr 04 09:43 PM
Squarer RonCEOApr 01Option Exercise0.0018,9060126,369Apr 04 09:43 PM
MOORE JOHN RVP, General CounselApr 01Option Exercise0.006,718046,472Apr 04 09:41 PM
Robbins Andrew RCOOApr 01Option Exercise0.009,843045,851Apr 04 09:42 PM
LEFKOFF KYLEDirectorMar 31Option Exercise3.9945,000179,45051,585Apr 04 09:41 PM
LEFKOFF KYLEDirectorMar 31Sale8.9245,000401,4006,585Apr 04 09:41 PM
BAUM CHARLES MDirectorMar 28Option Exercise3.8725,00096,75030,000Mar 30 05:23 PM
BAUM CHARLES MDirectorMar 28Sale9.2725,000231,7505,000Mar 30 05:23 PM